BK virus antibody titers and intensity of infections after renal transplantation. - Wikidata - wikimedia - TriplyDB

BK virus antibody titers and intensity of infections after renal transplantation.

BK virus antibody titers and intensity of infections after renal transplantation.

http://www.wikidata.org/entity/Q37239525

about

BK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infection The trichodysplasia spinulosa-associated polyomavirus: virological background and clinical implications.Pre-transplant immune factors may be associated with BK polyomavirus reactivation in kidney transplant recipients.BK Virus-associated Hemorrhagic Cystitis in Patients with Allogeneic Hematopoietic Cell Transplantation: Report of Three Cases Relationship of BK polyoma virus (BKV) in the urine with hemorrhagic cystitis and renal function in recipients of T Cell-depleted peripheral blood and cord blood stem cell transplantations Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients Polyomavirus BK neutralizing activity in human immunoglobulin preparations.Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy.Inhibitory interactions between BK and JC virus among kidney transplant recipients.Asymptomatic primary Merkel cell polyomavirus infection among adults.BK polyomavirus: emerging pathogen.Clinical significance of quantitative and qualitative detection of BK and JC virus in blood and urine of renal transplantation recipients.Immunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity.Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients.BK Polyomavirus and the Transplanted Kidney: Immunopathology and Therapeutic Approaches.BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results Human polyoma viruses and disease with emphasis on clinical BK and JC.BK polyomavirus infection and nephropathy: the virus-immune system interplay.Management of polyomavirus-associated nephropathy in renal transplant recipients.The human polyomavirus BK (BKPyV): virological background and clinical implications.BK virus infection: an update on diagnosis and treatment.KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.45 years after the discovery of human polyomaviruses BK and JC: Time to speed up the understanding of associated diseases and treatment approaches.BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.BK Virus Nephropathy: Histological Evolution by Sequential Pathology.Merkel cell polyomavirus IgG antibody levels are associated with progression to AIDS among HIV-infected individuals.A Difficult Decision: Atypical JC Polyomavirus Encephalopathy in a Kidney Transplant Recipient.Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values.BK polyomavirus-specific cellular immune responses are age-dependent and strongly correlate with phases of virus replication.Role of BK virus infection in end-stage renal disease patients waiting for kidney transplantation--viral replication dynamics from pre- to post-transplant.Inflammatory activation and recovering BKV-specific immunity correlate with self-limited BKV replication after renal transplantation.BK virus-specific immunity kinetics: a predictor of recovery from polyomavirus BK-associated nephropathy.PML risk stratification using anti-JCV antibody index and L-selectin.Longitudinal study of seroprevalence and serostability of the human polyomaviruses JCV and BKV in organ transplant recipients Human Herpesvirus 8 (HHV8) Transmission and Related Morbidity in Organ Recipients

P2860

Q28070240-F7DBC273-EB4A-4EA7-A6AB-5EA102B3F65C Q30617802-9DA71EB2-DB9C-4011-BF13-7B23397F6EAA Q33745763-C13C7E13-88C4-43D9-938D-AB9DCA13A584 Q33863365-94C02660-271B-48F4-8F07-59A1E84D1B9F Q33905299-5C97EA0A-9E1A-4E76-96C3-26FD46F09E71 Q34236633-00C05CA4-D3BD-4FD7-A762-5FC3945410DA Q34786755-A48126C8-A3F0-4706-91C3-F6721600DA7B Q34803324-048DB1BA-0024-4038-9F6E-52A44D067586 Q35720604-1F560922-250B-4CDC-9715-4547517307F2 Q36053618-F89DF1F2-FC83-4844-AAC2-8E022D40E551 Q36600128-441D880A-DECA-4AB1-B61B-F42944779E8E Q36876460-60FB407D-73D3-465F-86A1-6CF5239D07C5 Q37127201-68594603-76F8-4022-8080-2B19273A0B2B Q37302119-A27A26C2-2D74-478B-B085-C1277DA890F8 Q37375153-C8636FC2-AA74-4F95-B1C2-3425D2E7D0C0 Q37670279-4B1A19AD-E045-4EE0-ABCA-6DAAD3B53764 Q37671117-EB4F7EFA-3A60-462E-8DFE-F1937E2CCA4F Q37879442-9D0F3C81-96DB-4E53-A142-FBB4BE63039C Q38003050-B16B5295-5B6C-44FF-9FA4-5F3C8BF1AB2F Q38115582-52357881-4F24-4A89-AE7C-3F6B255213AD Q38191554-5F65A596-2FB1-40A8-AA2C-6ADD02F6D686 Q38652031-A81A32B5-400F-4866-8155-EDBF2900056E Q38801394-9E9F349E-C553-4722-9A3B-E9399B409820 Q39180715-9B6F95E6-7109-441C-AEB0-11CC5A604B46 Q40260844-5101FC77-01F3-40C1-BF53-7D7404D82747 Q40401078-AD9C7A24-D3EA-49FF-AFBC-8241281067FE Q40628732-B55A4BB3-3024-4D06-AB97-CB507264F279 Q40649540-8C8171D3-89CA-43FD-96E4-ABED54D530A2 Q40928069-EECBBC5D-E36C-4E1A-A5A2-65E33963C9BB Q42225033-4A60F384-7700-4287-8486-61D19CC01A08 Q42238363-843A4ABE-4575-454E-8EDA-699A901BC594 Q42252894-50E3FF33-7315-4EEE-BBC7-822B1B063E6A Q45364259-65A89994-ABA6-4D12-9449-12C6797C91EA Q48938768-707DC4EE-C0BA-4216-A929-4E01FBC180A4 Q56795644-296A7185-306F-47A5-9A90-4B364C8E03D3 Q58814204-247D6BB0-B697-4670-9ED0-4A3E6E4B3830

P2860

BK virus antibody titers and intensity of infections after renal transplantation.

http://www.wikidata.org/entity/Q37239525

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

BK virus antibody titers and intensity of infections after renal transplantation.

@en

BK virus antibody titers and intensity of infections after renal transplantation.

@nl

type

label

BK virus antibody titers and intensity of infections after renal transplantation.

@en

BK virus antibody titers and intensity of infections after renal transplantation.

@nl

prefLabel

BK virus antibody titers and intensity of infections after renal transplantation.

@en

BK virus antibody titers and intensity of infections after renal transplantation.

@nl

P1433

Q37239525-386E286B-DA88-4BF0-8ABD-64AA9A19ABA1

P1476

Q37239525-0DA7FCEE-D0D9-4323-9E24-769A5BDD0733

P2093

Q37239525-2B1353DA-7922-4336-9F44-2514F66FE603

Q37239525-6A6C3FBB-53A4-4FE5-A400-1E72D8894D81

Q37239525-9854EEFE-3AB9-40AB-92FA-825444E115D7

Q37239525-BF76C9FC-190A-4DCD-B096-156AEA2919CC

Q37239525-EB0F4FD2-B36A-4993-8E39-B5279AC70CB7

Q37239525-F33EA374-89C1-4561-88DC-3C84DDF19EDA

P2860

Q37239525-1F5B624B-B92B-4A1E-85AA-718A7B33A040

Q37239525-240BF84F-4649-4371-9B2D-D6B5F7B8293A

Q37239525-2F89B883-2EC4-49FB-B936-6DB019DF3FB1

Q37239525-3231E67C-5E99-474F-88CE-55F04E90CF47

Q37239525-46ECEAB5-328A-4DC1-9B2E-DCC269323727

Q37239525-5F394D96-3C36-4DB0-9E0F-24DE69E62423

Q37239525-69C5C799-12BA-4DCD-948E-AB658B28B533

Q37239525-6F7B6064-E998-4036-B4D2-9D68BC4E91F6

Q37239525-73FFB0D2-7EDA-4A40-848A-A79103F25386

Q37239525-7A756FE7-FFFE-46DB-82FD-8F4DF61CB591

P304

Q37239525-AC581869-F1FB-4FD2-9786-1772A97AC080

P31

Q37239525-E03F7C08-9452-4DBE-9B16-3EC564D79DF0

P356

Q37239525-D8EF1378-F7A4-422A-A7DC-432377A117F9

P433

Q37239525-35F76AE2-3226-4AB6-A9BD-F2076471343C

P478

Q37239525-1A1A2146-00F6-483C-8D0E-C1D4C6152F0D

P577

Q37239525-8828194D-42BE-411F-9FFF-C9815AAF5269

P5875

Q37239525-A506E197-3091-49FB-BD1F-17BAFDB2E6B8

P698

Q37239525-75763AEE-CF49-4344-9C7D-FF11A26FF6B8

P921

Q37239525-00160DB8-B54D-4C18-9C7C-9478E8F2A64A

P932

Q37239525-70B5F9D9-6C6A-4592-A8A4-50BCBC3C038E

P356

J.JCV.2008.06.009

P1433

Journal of Clinical Virology

P1476

BK virus antibody titers and intensity of infections after renal transplantation.

@en

P2093

Caroline Ryschkewitsch

http://www.w3.org/2001/XMLSchema#string

Daniel C Brennan

http://www.w3.org/2001/XMLSchema#string

Daniel L Bohl

http://www.w3.org/2001/XMLSchema#string

Eugene O Major

http://www.w3.org/2001/XMLSchema#string

Gregory A Storch

http://www.w3.org/2001/XMLSchema#string

Monique Gaudreault-Keener

http://www.w3.org/2001/XMLSchema#string

P2860

New human papovavirus (B.K.) isolated from urine after renal transplantation

Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays.

Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus.

Immunoglobulin G, A, and M responses to BK virus in renal transplantation.

Polyomavirus BK.

Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients.

Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo.

Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients.

Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches.

BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis.

P304

184-189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCV.2008.06.009

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23145497

http://www.w3.org/2001/XMLSchema#string

P698

18676176

http://www.w3.org/2001/XMLSchema#string

P921

P932

2701220

http://www.w3.org/2001/XMLSchema#string